Previously treated cases tested for RR-/MDR-TB in El Salvador

El Salvador: Previously treated cases tested for RR-/MDR-TB was 97.0% in 2024. ◆ Volatile

Latest (2024)
97.0%
Change on year
up 1,305.8%
World rank
61st
of 180 countries
All-time high
97.0%
in 2024
All-time low
2.2%
in 2010
Years of data
19
2005–2024

Previously treated cases tested for RR-/MDR-TB in El Salvador, 2005–2024

0204060801002005201420242005: 122007: 942008: 952009: 752010: 2.22011: 832012: 742013: 222014: 822015: 472016: 352017: 162018: 302019: 342020: 222021: 192022: 802023: 6.92024: 97

Source: World Health Organization, Global Health Observatory.

Analysis

El Salvador recorded 97.0% for previously treated cases tested for rr-/mdr-tb in 2024. That is the highest value across all 19 years on record.

The figure is up 1,305.8% on the previous year and up 18.3% over ten years.

Over the whole period, previously treated cases tested for rr-/mdr-tb in El Salvador peaked at 97.0% in 2024 and was at its lowest, 2.2%, in 2010.

That places El Salvador 61st out of 180 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Previously treated cases tested for RR-/MDR-TB in El Salvador, year by year

Annual values for Previously treated cases tested for RR-/MDR-TB (%) in El Salvador, 2005 to 2024.
Year Value Change
2005 12.0%
2007 94.0% +683.3%
2008 95.0% +1.1%
2009 75.0% -21.1%
2010 2.2% -97.1%
2011 83.0% +3672.7%
2012 74.0% -10.8%
2013 22.0% -70.3%
2014 82.0% +272.7%
2015 47.0% -42.7%
2016 35.0% -25.5%
2017 16.0% -54.3%
2018 30.0% +87.5%
2019 34.0% +13.3%
2020 22.0% -35.3%
2021 19.0% -13.6%
2022 80.0% +321.1%
2023 6.9% -91.4%
2024 97.0% +1305.8%

Averages by decade

DecadeAverage LowestHighest Years
2000s 69.0% 12.0% 95.0% 4
2010s 42.5% 2.2% 83.0% 10
2020s 45.0% 6.9% 97.0% 5

Countries ranked near El Salvador

  1. 58 Somalia 98.0% compare
  2. 58 Russia 98.0% compare
  3. 58 Saudi Arabia 98.0% compare
  4. 61 Ecuador 97.0% compare
  5. 61 Dominican Republic 97.0% compare
  6. 61 Ukraine 97.0% compare

See the full ranking of 193 places →

More health data for El Salvador

All data for El Salvador →

Frequently asked questions

What is previously treated cases tested for rr-/mdr-tb in El Salvador?
Previously treated cases tested for rr-/mdr-tb in El Salvador was 97.0% in 2024, according to World Health Organization, Global Health Observatory.
What is the highest previously treated cases tested for rr-/mdr-tb recorded in El Salvador?
The highest recorded value was 97.0% in 2024.
What is the lowest previously treated cases tested for rr-/mdr-tb recorded in El Salvador?
The lowest recorded value was 2.2% in 2010.
How does El Salvador rank for previously treated cases tested for rr-/mdr-tb?
El Salvador ranks 61st out of 180 countries with data for 2024.
Is previously treated cases tested for rr-/mdr-tb rising or falling in El Salvador?
Over the last ten years it is up 18.3%. The long-run trend across the full record is volatile.
Where does this El Salvador data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 19 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Previously treated cases tested for RR-/MDR-TB in El Salvador. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 02 September 2026, from https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/el-salvador/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/el-salvador/">Previously treated cases tested for RR-/MDR-TB in El Salvador</a> — Statizoid

About this data

Indicator
Previously treated cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
193 places, 3,089 data points, 2005–2024
Last refreshed